Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced injectables.

Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot that discusses obesity

A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded weight loss drugs.

The Super Bowl spot is part of a larger campaign as Hims & Hers continues to highlight its weight loss treatments. The ad will air after Feb. 9 in 30-, 15- and 6-second versions on both broadcast and digital channels. The brand worked with Tinuiti on media duties.

Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the heart of the ongoing GLP-1 phenomenon.

Telehealth company's spot decries medications from others as "priced for profits, not patients," while its own weight-loss drugs are "affordable."